Table 3 Comparison of VAS activity pain, DASH scores, and paracetamol intake within and between the groups
VAS activity pain (mean, SD) | IFC group (n = 18) | Sham group (n = 17) | p** |
|---|---|---|---|
Post-treatment | 3.9 ± 1.5 | 4.7 ± 1.5 | |
6th week post-treatment | 2 ± 1.7 | 3 ± 1.5 | 0.793 |
18th week post-treatment | 0.7 ± 1.1 | 1.7 ± 1.4 | |
p* | < 0.001 | < 0.001 | |
DASH scores | |||
Post-treatment | 28 ± 11 | 38.4 ± 17.5 | |
6th week post-treatment | 15.3 ± 9.2 | 23.3 ± 13 | 0.299 |
18th week post-treatment | 7.7 ± 7.3 | 12.5 ± 11.3 | |
p* | < 0.001 | < 0.001 | |
Paracetamol intake (g/week) | |||
Post-treatment | 9.7 ± 7.6 | 11 ± 9.2 | |
6th week post-treatment | 3.7 ± 4.5 | 6.7 ± 8.2 | 0.583 |
18th week post-treatment | 1.2 ± 2.2 | 4.7 ± 6.7 | |
p* | < 0.001 | < 0.001 | |